Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Dasatinib × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Leukemia 8 Leukemia, Myeloid, Chronic-Phase 7 Burkitt Lymphoma 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Recurrence 3 Prostatic Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Philadelphia Chromosome 2 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm, Residual 2 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Glioma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostate Cancer Recurrent 1 Primary Myelofibrosis 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neuroblastoma 1

Interventions

X-Rays 6 Phantoms, Imaging 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Biopsy 4 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 LY3023414 2 Etoposide 2 thymoglobulin 1 temsirolimus 1 talazoparib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Thiotepa 1 Tacrolimus 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡